CompletedNCT02348203
Aspirin and Zileuton Effects on Tobacco-Related Genes
About this title
Read the official source — NCT02348203Medication studyAges 18+United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Tucson and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: January 13, 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 63
- Sponsor
- National Cancer Institute (NCI)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT02348203
- Official title
Show the full official title
Clinical Study of the Effect of Combined Treatment of Aspirin and Zileuton on Biomarkers of Tobacco-Related Carcinogenesis in Current Smokers
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Tucson · Boston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Cancer Institute (NCI), a research institute.
Did this study involve medication?
Yes. The study involved medication, including Aspirin and Zileuton.
Who was this study for?
Listed age limits: from 18 years.
